AR031599A1 - Vacunas para el virus herpes equino tipo 1: virus que hospeda mutaciones dentro del gen inmediato precoz - Google Patents
Vacunas para el virus herpes equino tipo 1: virus que hospeda mutaciones dentro del gen inmediato precozInfo
- Publication number
- AR031599A1 AR031599A1 ARP010103602A AR031599A1 AR 031599 A1 AR031599 A1 AR 031599A1 AR P010103602 A ARP010103602 A AR P010103602A AR 031599 A1 AR031599 A1 AR 031599A1
- Authority
- AR
- Argentina
- Prior art keywords
- immediate
- vhe
- isolates
- hev
- gene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16761—Methods of inactivation or attenuation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Se refiere a los aislados del virus herpes equino tipo 1(VHE-1)mutante, y en particular a los aislados VHE-1 que transportan mutaciones en el gen inmediato-precoz (IP) del genoma viral. Un panel de aislado del VHE-1 mutante se ha descripto en la presente. Los aislados del VHE-1 preferidos son aquellos que son de replicacion-competente y no patogénica. Los aislados del VHE-1 mutante de la presente invencion son utiles para formular composiciones de vacuna para impedir y tratar las infecciones por el VHE-1 en los equinos. Además la presente proporciona los métodos para determinar la patogenicidad de un VHE-1 presente en un equino que ha sido previamente inmunizado con un aislado de VHE-1 no patogénico.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62674800A | 2000-07-27 | 2000-07-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR031599A1 true AR031599A1 (es) | 2003-09-24 |
Family
ID=24511676
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP010103602 AR031599A1 (es) | 2000-07-27 | 2001-07-27 | Vacunas para el virus herpes equino tipo 1: virus que hospeda mutaciones dentro del gen inmediato precoz |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1317481A2 (es) |
JP (1) | JP2004512826A (es) |
AR (1) | AR031599A1 (es) |
AU (1) | AU2001282997A1 (es) |
CA (1) | CA2417340A1 (es) |
DE (1) | DE01961753T1 (es) |
MX (1) | MXPA03000823A (es) |
NZ (1) | NZ523772A (es) |
WO (1) | WO2002009750A2 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1129722A1 (en) | 2000-02-17 | 2001-09-05 | Boehringer Ingelheim Vetmedica Gmbh | gM-negative EHV-mutants |
AR040601A1 (es) | 2002-07-19 | 2005-04-13 | Boehringer Ingelheim Vetmed | Mutantes ehv negativos de gm sin elementos heterologos |
WO2004011677A2 (en) * | 2002-07-26 | 2004-02-05 | Animal Health Trust | Viral marker |
US8916371B2 (en) * | 2012-03-20 | 2014-12-23 | Merial Limited | Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein C and uses thereof |
CN108315487B (zh) * | 2018-04-16 | 2021-06-22 | 福建省农业科学院生物技术研究所 | 一种检测鳗鲡疱疹病毒的引物组、试剂盒及其应用 |
CN110885794A (zh) * | 2019-10-30 | 2020-03-17 | 新疆农业大学 | 一种马疱疹病毒1型及其应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5292653A (en) * | 1989-09-27 | 1994-03-08 | Novagene, Inc. | Equine herpesvirus 1 tk mutants |
EP0668355B1 (en) * | 1993-12-20 | 1999-04-07 | Akzo Nobel N.V. | Vaccine for the protection of horses against equine herpesvirus infection |
-
2001
- 2001-07-27 MX MXPA03000823A patent/MXPA03000823A/es unknown
- 2001-07-27 NZ NZ523772A patent/NZ523772A/en unknown
- 2001-07-27 JP JP2002515303A patent/JP2004512826A/ja active Pending
- 2001-07-27 EP EP01961753A patent/EP1317481A2/en not_active Ceased
- 2001-07-27 CA CA 2417340 patent/CA2417340A1/en not_active Abandoned
- 2001-07-27 AR ARP010103602 patent/AR031599A1/es not_active Application Discontinuation
- 2001-07-27 AU AU2001282997A patent/AU2001282997A1/en not_active Abandoned
- 2001-07-27 DE DE2001961753 patent/DE01961753T1/de active Pending
- 2001-07-27 WO PCT/US2001/023612 patent/WO2002009750A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2417340A1 (en) | 2002-02-07 |
WO2002009750A2 (en) | 2002-02-07 |
EP1317481A2 (en) | 2003-06-11 |
NZ523772A (en) | 2004-06-25 |
JP2004512826A (ja) | 2004-04-30 |
WO2002009750A3 (en) | 2003-03-27 |
DE01961753T1 (de) | 2004-03-11 |
MXPA03000823A (es) | 2003-09-10 |
AU2001282997A1 (en) | 2002-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2140418T3 (es) | Flavivirus quimericos y/o flavivirus de crecimiento restringido. | |
MX342639B (es) | Virus de la influenza recombinantes de alta titulacion para vacunas y terapia genica. | |
PL398576A1 (pl) | Preparaty szczepionek, preparaty farmaceutyczne, atenuowany wirus grypy, sposoby szczepienia, sposoby zapobiegania chorobie zakaznej, sposoby leczenia lub profilaktyki nowotworów, kompozycje szczepionek i kompozycje farmaceutyczne | |
NO20025171L (no) | DNA-transfeksjonssystem for fremstilling av smittsom influensavirus | |
NL300364I1 (nl) | Recombinante influenzavirussen voor vaccins en gentherapie | |
CR8935A (es) | Inhibidores de la arn polimerasa dependiente del arn del virus de la hepatitis c y composiciones | |
ATE485056T1 (de) | Verbesserte impfstoffe | |
AR038596A1 (es) | Sistemas de expresion de virus parainfluenza recombinantes y vacunas que comprenden antigenos heterologos derivados de metapneumovirus | |
CY1110359T1 (el) | Εμβολια με βαση σιρκοϊους χοιρων | |
HUP9903822A2 (hu) | Polinukleotid-vakcinakészítmény sertések szaporodásbiológiai és légzőszervi kórképei ellen | |
DE60024112D1 (de) | Influenzavirus-impfstoffzusammensetzung | |
Thiry et al. | Recombination in the alphaherpesvirus bovine herpesvirus 1 | |
DK1425404T3 (da) | Vaccinia-MVA-E3L-mutanter og anvendelse deraf | |
AR031599A1 (es) | Vacunas para el virus herpes equino tipo 1: virus que hospeda mutaciones dentro del gen inmediato precoz | |
WO2002072802A3 (en) | Live attenuated strains of prrs virus | |
CY1106570T1 (el) | Σταθερες, εξασθενημενες μεταλλαγμενες μορφες ιου λυσσας και ζωντανια εμβολια αυτων | |
ES2141093T3 (es) | Herpesvirus equinos (ehv) que contienen adn ajeno, procedimiento para su obtencion y su empleo en vacunas. | |
AR040623A1 (es) | Vacuna contra el virus de la aftosa. | |
ES2120989T3 (es) | Vector virico recombinante de tipo varicela-zoster. | |
US20200138937A1 (en) | Genetically Attenuated Nucleic Acid Vaccine | |
ES2132330T3 (es) | Vacuna para la proteccion de caballos frente a la infeccion por el virus del herpes equino. | |
PE20001331A1 (es) | Identificacion de genotipos senv | |
AR034771A1 (es) | Formulacion vacunal potenciada por la combinacion de un adn con un antigeno | |
BR0101523A (pt) | Pestivìrus, vacina, e, processos para imunizarcontra doença induzida por pestivìrus e parafabricar uma vacina para a proteção de um animalcontra um pestivìrus | |
AR035809A1 (es) | Cromosomas artificiales que comprenden secuencias de ehv |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |